ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,277 | +35.6% | 47,527 | +28.2% | 0.11% | +17.2% |
| Q1 2023 | $942 | -99.8% | 37,073 | +223.9% | 0.09% | +86.0% |
| Q3 2022 | $378,000 | -64.5% | 11,447 | -62.1% | 0.05% | -68.8% |
| Q2 2022 | $1,065,000 | +104.0% | 30,241 | +166.5% | 0.16% | +128.6% |
| Q1 2022 | $522,000 | +141.7% | 11,346 | +51.1% | 0.07% | +29.6% |
| Q1 2020 | $216,000 | -22.6% | 7,511 | +70.7% | 0.05% | +68.8% |
| Q4 2019 | $279,000 | +3.0% | 4,400 | -54.2% | 0.03% | -13.5% |
| Q3 2019 | $271,000 | -71.4% | 9,600 | -73.2% | 0.04% | -65.1% |
| Q2 2019 | $949,000 | -25.7% | 35,800 | -48.6% | 0.11% | -17.8% |
| Q1 2019 | $1,277,000 | +408.8% | 69,613 | +244.3% | 0.13% | +344.8% |
| Q4 2018 | $251,000 | -74.0% | 20,217 | -84.9% | 0.03% | -43.1% |
| Q1 2018 | $966,000 | – | 133,969 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |